The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS, INC. | COM | 00847X104 | 17,760,750 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | |||
| ALUMIS INC. | COM | 022307102 | 93,576,170 | 4,247,670 | SH | SOLE | 4,247,670 | 0 | 0 | |||
| AtaiBeckley Inc. | COM | 04650F101 | 9,735,000 | 2,750,000 | SH | SOLE | 2,750,000 | 0 | 0 | |||
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 54,178,835 | 1,364,019 | SH | SOLE | 1,364,019 | 0 | 0 | |||
| Celldex Therapeutics, Inc. | COM | 15117B202 | 10,020,760 | 315,913 | SH | SOLE | 315,913 | 0 | 0 | |||
| CG Oncology, Inc. | COM | 156944100 | 150,349,360 | 2,221,474 | SH | SOLE | 2,221,474 | 0 | 0 | |||
| Corvus Pharmaceuticals, Inc. | COM | 221015100 | 26,790,939 | 1,831,233 | SH | SOLE | 1,831,233 | 0 | 0 | |||
| Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 7,700,203 | 212,010 | SH | SOLE | 212,010 | 0 | 0 | |||
| Denali Therapeutics Inc. | COM | 24823R105 | 23,231,443 | 1,209,971 | SH | SOLE | 1,209,971 | 0 | 0 | |||
| GH Research PLC | ORD | G3855L106 | 4,435,818 | 315,492 | SH | SOLE | 315,492 | 0 | 0 | |||
| Hinge Health, Inc. | CL A | 433313103 | 8,498,624 | 220,400 | SH | SOLE | 220,400 | 0 | 0 | |||
| Jade Biosciences, Inc. | COM | 008064206 | 4,496,000 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | 12,187,992 | 146,332 | SH | SOLE | 146,332 | 0 | 0 | |||
| Minerva Neurosciences, Inc. | COM | 603380205 | 11,969,265 | 1,986,600 | SH | SOLE | 1,986,600 | 0 | 0 | |||
| OnKure Therapeutics, Inc. | COM CL A | 68277Q105 | 5,985,542 | 1,445,783 | SH | SOLE | 1,445,783 | 0 | 0 | |||
| Verastem, Inc. | COM | 92337C203 | 16,677,144 | 3,146,631 | SH | SOLE | 3,146,631 | 0 | 0 | |||
| Zura Bio Ltd | CL A | G9TY5A101 | 2,677,500 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||